Antidepressant effects of pramipexole, a novel dopamine receptor agonist

Journal of Neural Transmission

Volumn 104, Issue 4-5, 1997, Pages 525-533

  Maj, J ^a   Rogoz Z ^a   Skuza, G ^a   Kolodziejczyk K ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressant activity; Dopamine receptors; Pramipexole; Rats

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DEXAMPHETAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; IMIPRAMINE; PRAMIPEXOLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG SPECIFICITY; FORCED SWIMMING TEST; HYPERACTIVITY; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BENZOTHIAZOLES; COERCION; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SWIMMING; THIAZOLES;

EID: 0030828275     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01277669     Document Type: Article

References (26)

1. Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19: 377-395
2. 3-prefering dopamine agonist. Neurosci Lett 196: 97-100
3. 2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo. Eur J Pharmacol 200: 65-72
4. Cervo L, Grignaschi G, Rossi C, Samanin R (1991) Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur J Pharmacol 196: 217-222
5. Górka Z, Wojtasik E, Kwiatek H, Maj J (1979) Action of serotoninmimetics in the behavioral despair test in rats. Comm Psychopharmacol 3: 133-136
6. 2-receptors. J Pharm Pharmacol 41: 555-558
7. 3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiography study. J Pharmacol Exp Ther 264: 991-1001
8. 1) and dopamine receptors. In: Paton W, Michell J, Turner P (eds) IUPHAR 9th International Congress of Pharmacology, London, 1984. Proceedings, vol 3. Macmillan, London, pp 137-143
9. Maj J (1986) Repeated treatment with antidepressant drugs: responses mediated by brain dopamine receptors. In: Hippius H, Klerman GL, Matussek N (eds) New results in depression research. Springer, Berlin Heidelberg New York Tokyo, pp 90-98
10. Maj J, Rogóż Z, Skuza G (1982) Fluvoxamine - a new antidepressant drug fails to show antiserotonin activity. Eur J Pharmacol 81: 287-292
11. Maj J, Rogóż Z, Skuza G, Sowińska H (1984) Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol 36: 127-130
12. Maj J, Rogóż Z, Skuza G, Sowińska H (1985) The effect of repeated treatment with antidepressant drugs on the action of D-amphetamine and apomorphine in rats. In: Kelemen K, Magyar K, Vizi ES (eds) Neuropharmacology '85. Akademiái Kiadó, Budapest, pp 133-139
13. Maj J, Rogóż Z, Skuza G, Sowińska H (1989) Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist. J Neural Transm 78: 1-8
14. 2 receptors in the rat brain. Eur J Pharmacol 304: 49-54
15. Maj J, Rogóż Z, Skuza G, Kołodziejczyk K (1997) The behavioural effects of pramipexole, a novel dopamine receptor agonist on the dopamine system. Eur J Pharmacol (submitted)
16. Malinge M, Bourin M, Colombel MC, Larousse C (1988) Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test. Psychopharmacology 96: 104-109
17. 2 receptor agonist. Eur J Pharmacol 215: 161-170
18. 4 receptors. Eur J Pharmacol, Mol Pharmacol Sect 290: 29-36
19. Nixon MK, Hascoet M, Bourin M, Colombel MC (1994) Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology 115: 59-64
20. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioral despair in rats, a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391
21. Sautel F, Griffon N, Lévesque D, Pilon C, Schwartz J-C, Sokoloff P (1995) A functional test identifies dopamine agonists selective for D3 versus D2 receptors. NeuroReport 6: 329-332
22. Schneider CS, Mierau J (1987) Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine. J Med Chem 30: 494-488
23. Serra G, Argiolas A, Klimek V, Fadda F, Gessa GL (1979) Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci 25: 415-424
24. Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74: 195-206
25. 3 receptors. Eur J Pharmacol 263: 235-243
26. Willner P, Lappas S, Cheeta S, Muscat R (1994) Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology 115: 454-462